The therapeutic potential of P2X7 agonists and antagonists is currently being intensively studied for the treatment of a number of diseases, including chronic neuropathic and inflammatory pain, cancer and intracellular infections as well as neuroinflammation and neurodegenerative diseases. The gene discussed is P2RX7; the disease is cancer.